期刊文献+

HBV pre-X转染HepG2细胞后差异表达基因的筛选 被引量:2

Screening of genes differentially expressed in HepG2 cells transfected with HBV pre-X
下载PDF
导出
摘要 目的:检测HBV pre-X在真核表达载体pcDNA3.1-myc-his-HBV pre-X转染的HepG2细胞中的表达,并筛选其中的代谢相关差异表达基因.方法:将构建的真核表达载体pcDNA3.1-myc-his-HBV pre-X转染HepG2细胞后蛋白免疫印迹检测;将pcDNA3.1-myc-his-HBV pre-X和pcDNA3.1-myc-his载体分别转染HepG2细胞后,提取mRNA后逆转录为cDNA,运用基因表达谱芯片技术分析差异表达基因.结果:构建的真核表达载体经ApaⅠ、BstⅪ双酶切鉴定,转染HepG2细胞后HBV pre-X表达经蛋白免疫印迹证实;经基因表达谱芯片分析发现,其中基因表达水平显著上调和下调的分别是200个和62个.结论:筛选HBV pre-X转染HepG2细胞后的代谢相关差异表达基因,从而为乙型肝炎病毒合并糖尿病、脂肪肝等代谢性疾病的分子生物学机制的研究提供了重要依据. AIM:To detect the expression of HBV pre-X and screen the different gene expression in HepG2 cells transfected with HBV pre-X using gene chip technology.METHODS:The expressive vector of pcDNA3.1-myc-his-HBV pre-X was transfected into HepG2 cell line.The expression of HBV pre-X protein was observed by western-blotting method.cDNA microarray technique was applied to de-tect the differentially expressed genes in HepG2 transfected either with pcDNA3.1-myc-his-HBV pre-X or with pcDNA3.1-myc-his.RESULTS:The expressive vector was confirmedby restriction enzyme digestion.The expression of HBV pre-X protein was confirmed by west-ern-blotting method.High quality mRNA and cDNA was prepared and successful microarray screening was conducted.Based on the scanning results,200 genes were found to be up-regulated and 62 genes down-regulated in HepG2 cell line transfected with HBV pre-X.CONCLUSION:cDNA microarray technology is successfully used to screen the genes differen-tially expressed in HepG2 cell line transfected with HBV pre-X,which may bring some new clues for studying the molecular biology mecha-nism of hepatitis B virus with metabolic diseases.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第33期3724-3728,共5页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30600524~~
关键词 乙型肝炎病毒前X基因 HEPG2细胞 基因芯片 差异表达基因 HBV pre-X HepG2 cell Microarray Dif-ferential expression gene
  • 相关文献

参考文献9

二级参考文献87

  • 1董菁,成军,王勤环,皇甫竞坤,施双双,张国庆,洪源,李莉,斯崇文.慢性乙型肝炎患者体内乙型肝炎病毒DNA序列异质性及准种特点的研究[J].中华医学杂志,2002,82(2):81-85. 被引量:37
  • 2薛红安,杨倩,刘拉羊,成军,董菁.乙型肝炎病毒全X基因的克隆及原核表达[J].第四军医大学学报,2004,25(23):2133-2135. 被引量:1
  • 3范建高,朱军,李新建,李锐,戴菲,宋晓敏,陈兰,李锋,陈世耀.上海市成人脂肪肝患病率及其危险因素流行病学调查[J].中华肝脏病杂志,2005,13(2):83-88. 被引量:583
  • 4Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1515
  • 5Soresi M, Tripi S, Franco V, et al. Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. Liver Int, 2006, 26:1119-1125.
  • 6Bondini S, Younossi ZM. Non-alcoholic fatty liver disease and hepatitis C infection. Minerva Gastroenterol Dietol, 2006, 52: 135-143.
  • 7Fan JG, Chitturi S. Hepatitis B and fatty liver: causal or coincidental? J Gastroenterol Hepatol, 2008; 23:779-782.
  • 8Thomopoulos KC, Arvaniti V, Tsamantas AC, et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol, 2006, 18: 233-237.
  • 9Gordon A, McLean CA, Pedersen JS, et al. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol, 2005, 43: 38-44.
  • 10Fan JG, Saibara T, Chitturi S, et al. What are the risk factors and settings of nonalcoholic fatty liver disease in Asia Pacific. J Gastroenterol Hepatol, 2007, 22: 794-800.

共引文献84

同被引文献16

  • 1陈公英,陈智,任苏平,吕国才,李敏伟,周慧明,姚航平.乙型肝炎病毒对干扰素-γ受体表达及其信号通路的影响[J].中华传染病杂志,2004,22(4):250-254. 被引量:4
  • 2Mohammad Alizadeh AH,Fallahian F,Alavian SM,Ranjbar M,Hedayati M,Rahimi F,Khedmat H,Etemadi A,Zali MR,Azizi F.Insulin resistance in chronic hepatitis B and C.Indian J Gastroenterol 2006; 25:286-289.
  • 3Custro N,Carroccio A,Ganci A,Scafidi V,Campagna P,Di Prima L,Montalto G.Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis.Diabetes Metab 2001; 27:476481.
  • 4Fermo E,Bianchi P,Vercellati C,Marcello AP,Garatti M,Marangoni O,Barcellini W,Zanella A.Recessive hereditary methemoglobinemia:two novel mutations in the NADH-cytochrome b5 reductase gene.Blood Cells Mol Dis 2008; 41:50-55.
  • 5Maran J,Guan Y,Ou CN,Prchal JT.Heterogeneity of the molecular biology of methemoglobinemia:a study of eight consecutive patients.Haematologica 2005; 90:687-689.
  • 6Percy MJ,Oren H,Savage G,Irken G.Congenital methaemoglobinaemia Type I in a Turkish infant due to a novel mutation,Pro144Ser,in NADH-cytochrome b5 reductase.Hematol j 2004; 5:367-370.
  • 7Lukyanenko LM,Kozlova NM,Slobozhanina EI.Activity of membrane-bound NADH-methemoglobin reductase and physical state of lipids in erythrocyte membranes.Bioelectrochemistry 2004; 62:191-193.
  • 8Jezela-Stanek A,Ciara E,Malunowicz EM,Korniszewski L,Piekutowska-Abramczuk D,Popowska E,Krajewska-Walasek M.Mild Smith-Lemli-Opitz syndrome:further delineation of 5 Polish cases and review of the literature.Eur J Med Genet 2008; 51:124-140.
  • 9Waye JS,Eng B,Potter MA,Nowaczyk MJ,McFadden D,Langlois S.De novo mutation of the DHCR7 gene in a fetus with severe Smith-Lemli-Opitz (or RSH) syndrome.Am J Med Genet A 2007; 143A:1799-1801.
  • 10Waye JS,Eng B,Nowaczyk MJ.Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis.Prenat Diagn 2007; 27:638-640.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部